Applications of
Cheminformatics & Chemical Modelling
to Drug Discovery
Des Jarlais, R



SignUp
(to Register)

Login
User Name
Password

Forgot Password?

Renee DesJarlais, Johnson & Johnson
Dr. DesJarlais is Principal Scientist in the department of Molecular Design and Informatics at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Her work focuses on the use of computational chemistry in support of drug discovery. She has experience with a wide variety of computational techniques with particular expertise in the area of structure-based drug design.

Dr. DesJarlais received her Ph.D. in pharmaceutical chemistry from the University of California, San Francisco working in the laboratory of Dr. Irwin D. Kuntz, Jr. She also holds a Doctor of Pharmacy, a professional pharmacy degree. Dr. DesJarlais has published over 35 papers in peer-reviewed journals, authored 5 book chapters and is co-inventor on 4 issued patents.

Abstract
Molecular Docking as a Virtual Screening Tool

Renee L. DesJarlais, Alan C. Gibbs, Venkatraman Mohan, Edward P.Jaeger, Maxwell D. Cummings, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
665 Stockton Drive, Exton PA 19341 and 8 Clarke Drive, Cranbury NJ 08512


When embarking on a screening campaign, it is often necessary to limit the number of compounds to be tested. Occasionally resources will dictate testing only a relatively small subset of available molecules. In such cases, it is important to select compounds for screening with the highest likelihood of success. Where a structure of the molecular target is available, a variety of docking tools are available for virtual screening of a compound collection. It is difficult to find unbiased assessments and comparisons of these docking methods as virtual screening tools. We sought to do our own tests with a variety of docking methods on a variety of targets. We seeded a 1000 molecule database of drug-like molecules from the MDDR with known actives for 5 different targets. The performance of six different programs was evaluated based on the ability of each program to rank actives well, the correlation of scores with binding affinity and the ability of each program to find modes consistent with crystallographically determined structures. Detailed analysis of the results will be presented, and some specific challenges of this type of study will be discussed.

News and Announcements
Advanced Training Week
Drug Discovery Design Methods
Hyderabad, 7-10 Dec 2009
Oxford, 20-24 July 2009
InterAction Meetings 2008
Advances in Drug Discovery Informatics
Philadelphia, 14-17 Oct. 2008
Hyderabad, 11-12 Dec 2009
InnovationWell
InnovationWell Workshops
Virtual Proceedings for Members
eCheminfo 2005 InterAction Meeting
eCheminfo 2004 Conference
Featured Talks for Visitors
Open Archives as a Route for the Capture, Dissemination and Access to Chemical Information – Simon Coles, University of Southampton
Cheminfostream Blog
Cheminformatics & Community News
Sponsors
Partners

© Copyright 2004-2007 Colayer 
Colayer